FDA DEVICE FACTS
Medtronic HV-R™ Bone Cement, Kyphon™ Xpede™ Bone Cement, CD Horizon™ Fenestrated Screw Set
Medtronic Sofamor Danek USA, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
CD Horizon™ Fenestrated Screw Set When used without cement, CD Horizon™ Fenestrated Screws (with or without Sextant™ or Longitute™ instrumentation) are intended for posterior, non- cervical fixation as an adjunct to fusion for the following indications: degenerative d isc disease (DDD - defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, tumor and/or trauma (i.e., fracture or dislocation), spinal stenosis, curvatures (i.e., scoliosis, kyphosis, or lordosis), pseudarthrosis, and/or failed previous fusion. When used in conjunction with Medtronic HV-R™ Fenestrated Screw Cement or Kyphon™ Xpede™ Bone Cement, CD Horizon™ Fenestr ated Screws are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time in patients with advanced stage tumors involving the thoracic, lumbar, and sacral spine in whom life expectancy is of insufficient duration to permit achievement of fusion. CD Horizon™ Fenestrated Screws augmented with Medtronic HV-R™ Fenestrated Medtronic Confidential A001 - K191148 FDA Response to Questions 1293462 Screw Cement or Kyphon™ Xpede™ Bone Cement are for use at spina l levels where the structural integrity of the spine is not severely compromised. Kyphon™ Xpede™ Bone Cement Kyphon™ Xpede™ Bone Cement is indicated for the treatment of pa thological fractures of the vertebral body due to osteoporosis, cancer, or benign lesions using a cementoplasty (i.e. kyphoplasty or vertebroplasty) procedure. It is also indi cated for the fixation of pathological fractures of the sacral vertebral body or ala usin g sacral vertebroplasty or sacroplasty. Cancer includes multiple myeloma and metastatic le sions, including those arising from breast or lung cancer, or lymphoma. Benign lesions include hemangioma and giant cell tumor. Pathological fracture may include a symptomat ic microfracture (as documented by appropriate imaging and/or presence of a lytic lesion) without obvious loss of vertebral body height. When used in conjunction with CD Horizon™ Fenestrated Screws, K yphon™ Xpede™ Bone Cement is intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced s tage tumors involving the thoracic, and lumbar, or sacral spine in whom life expectancy is of insufficient duration to permit achievement of fusion. CD Horizon™ Fenestrated Screws augmented with Kyphon™ Xpede™ Bone Cement are for use at spinal levels where the structural integrity of the spine is not severely compromised. Medtronic HV-R™ Fenestrated Screw Cement When used in conjunction with CD Horizon™ Fenestrated Screws, M edtronic HV-R™ Fenestrated Screw Cement is intended to restore the integrity of the spinal column, even in the absence of fusion for a limited time in patients with advan ced stage tumors involving the thoracic, and lumbar, or sacral spine in whom life expectancy is of insufficient duration to permit achievement of fusion. Medtronic HV-R™ Fenestrated Screw Cement is limited to use at spinal levels where the structural integrity of the s pine is not severely compromised. Medtronic Confidential A001 - K191148 FDA Response to Questions 1293462
V. Comparison of the Technological Characteristics with the Predicate Device: The primary predicate for the subject devices is CD Horizon™ Fen estrated Screw Set (K171938, S.E. 10/23/2017). The subject CD Horizon™ fenestrated screws have the same or similar indications, intended use, same or similar overall design, packaging, sterilization and materials as the following FDA primary predicate cleared in K171938 (S.E. 10/23/2017) and K170679 (S.E. 05/11/2017). The predicate and sub ject new fenestrated screws have the identical function and scientific fundamental technology. There are no technology changes to the existing CD Horizon™ Fene strated Screw Set devices or the associated existing bone cements. However, the CD Horizon™ Fenestrated Screw Set system, Medtronic HV-R™ Fenestrated Screw Cement and Kyphon™ Xpede™ Bone Cement labeling has been updated to reflect the same indic ations for use as the predicates Kyphon™ Xpede™ Bone Cement (K163032, S.E. 02/27/2017), Kyphon™ HV- R™ Bone Cement (K180700, S.E. 05/18/2018), Medtronic HV-R™ Bone Cement (K152604, S.E. 01/06/2016), CD Horizon™ Fenestrated Screw Set ( K171938, S.E. 10/23/2017) and CD Horizon™ Fenestrated Screw Set (K170347, S.E. 04/04/2017).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。